Mabpharm Ltd.

21
Strong Sell
  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: KYG5780F1046
HKD
0.44
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
700.00
279.00
96.00
65.00
99.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
700.00
279.00
96.00
65.00
99.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
67.00
77.00
93.00
116.00
107.00
76.00
Operating Expenses
11.00
11.00
10.00
8.00
2.00
4.00
General and Administration Expenses
520.00
244.00
126.00
107.00
87.00
56.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
695.00
409.00
319.00
328.00
458.00
209.00
Operating Profit (PBDIT) excl Other Income
5.00
-129.00
-222.00
-263.00
-358.00
-209.00
Other Income
7.00
2.00
2.00
25.00
9.00
6.00
Operating Profit (PBDIT)
80.00
-61.00
-153.00
-177.00
-295.00
-175.00
Interest
11.00
11.00
10.00
8.00
2.00
4.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
64.00
66.00
67.00
59.00
52.00
27.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
4.00
-138.00
-231.00
-245.00
-351.00
-207.00
Provision for Tax
-57.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.00
-138.00
-231.00
-245.00
-351.00
-207.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.01
-0.03
-0.06
-0.06
-0.09
-0.05
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 150.27% vs 190.70% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 104.01% vs 41.74% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 2.46% vs 8.10% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 144.67% vs 40.03% in Dec 2024

Compare Profit and Loss Results of Mabpharm Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
No of Months
12
12
Operating Income
700.00
2,700.00
-2,000.00
-74.07%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
700.00
2,700.00
-2,000.00
-74.07%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
67.00
644.00
-577.00
-89.60%
Operating Expenses
11.00
33.00
-22.00
-66.67%
General and Administration Expenses
520.00
172.00
348.00
202.33%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
695.00
1,745.00
-1,050.00
-60.17%
Operating Profit (PBDIT) excl Other Income
5.00
954.00
-949.00
-99.48%
Other Income
7.00
96.00
-89.00
-92.71%
Operating Profit (PBDIT)
80.00
1,851.00
-1,771.00
-95.68%
Interest
11.00
33.00
-22.00
-66.67%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
64.00
801.00
-737.00
-92.01%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
971.00
-967.00
-99.59%
Provision for Tax
-57.00
-10.00
-47.00
-470.00%
Profit After Tax
61.00
976.00
-915.00
-93.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.015
0.2447
-0.23
-93.87%
Profit And Loss - Net Sales
Net Sales 700.71 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 150.27% vs 190.70% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.21 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 104.01% vs 41.74% in Dec 2024

Profit And Loss - Interest
Interest 11.72 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.46% vs 8.10% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 61.96 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 144.67% vs 40.03% in Dec 2024